10-Q: Chemed Reports Q1 2026 Results: Mixed Performance Across Segments

Chemed Corporation's Q1 2026 filing reveals a 1.6% increase in consolidated revenue driven by VITAS, while Roto-Rooter experienced a slight decline, alongside significant stock repurchases.

Summary

• Chemed Corporation reported Q1 2026 consolidated service revenues and sales of $657.5 million, a 1.6% increase compared to $646.9 million in Q1 2025.
• VITAS segment revenue grew by 3.1% to $420.0 million, primarily due to a 2.2% increase in days of care and a 2.6% rise in Medicare reimbursement rates.
• Roto-Rooter segment revenue decreased by 0.9% to $237.5 million, impacted by declines in commercial and residential services.
• Net income for the quarter was $66.3 million, down from $71.8 million in the prior year's quarter, with diluted EPS at $4.84 compared to $4.86.
• The company repurchased $197.7 million of its stock in Q1 2026, a significant increase from $33.2 million in Q1 2025, and has $229.6 million remaining under its authorization.
• A new $450 million revolving credit facility was established on April 10, 2026, replacing the previous agreement.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this filing as moderately positive, with stable revenue growth driven by the VITAS segment and strong capital return initiatives through stock repurchases, though tempered by a slight decline in net income and Roto-Rooter's performance.

Positives

• VITAS segment revenue increased by 3.1% to $420.0 million, driven by a 2.2% increase in days of care and a 2.6% rise in Medicare reimbursement rates.
• Plumbing and drain cleaning revenues at Roto-Rooter saw increases due to higher pricing and service mix shifts.
• The company maintained compliance with all debt covenants.
• A new, larger revolving credit facility of $450 million was secured, providing enhanced liquidity.
• The company's effective tax rate remained stable at 25.4% in Q1 2026 compared to 25.0% in Q1 2025.
• Stock repurchases totaling $197.7 million demonstrate a commitment to returning capital to shareholders.

Negatives

• Consolidated net income decreased to $66.3 million from $71.8 million in the prior year's quarter.
• Diluted EPS slightly decreased to $4.84 from $4.86.
• Roto-Rooter segment revenue declined by 0.9% due to decreases in commercial and residential services.
• VITAS experienced a significant decrease (-26.4%) in continuous care days.
• Implicit price concessions and credit memos increased significantly at Roto-Rooter, particularly in water restoration.
• Selling, general, and administrative expenses increased by 8.2% to $114.3 million, partly due to increased advertising at Roto-Rooter.

Risks

• Macroeconomic trends such as inflation, tariffs, and the impact of geopolitical events on fuel prices could adversely affect net sales and profitability.
• Disruptions from key service providers for pharmaceuticals and medical supplies could impact VITAS operations.
• Concentration of VITAS accounts receivable with Medicare and Medicaid programs presents a risk related to government payment timing and policies.
• The company is subject to various lawsuits and claims in the normal course of business, and regulatory agencies may impose penalties or withhold funding.
• Changes in Medicare and Medicaid laws and regulations are complex and subject to interpretation and change.

Future Outlook

The company anticipates that operating income and cash flows will be sufficient to operate the business and meet commitments for the foreseeable future. Management believes its liquidity and sources of capital are satisfactory for the company's needs. The company does not expect a material negative effect on net sales or profitability for the remainder of fiscal year 2026 from macroeconomic trends, but continues to evaluate potential effects and mitigation strategies for fiscal year 2027.

Management Comments

• "We continue to monitor macroeconomic trends and uncertainties such as inflation, the effects of recently implemented tariffs, and the potential imposition of modified or additional tariffs, as well as the impact of the war with Iran on fuel prices, which may have adverse effects on net sales and profitability."
• "Based on preliminary analysis of the potential effects of the announced tariffs and these other factors, we do not expect a material negative effect on our net sales or profitability for the remainder of fiscal year 2026."
• "Management continually evaluates cash utilization alternatives, including share repurchase, debt repurchase, acquisitions and increased dividends to determine the most beneficial use of available capital resources."
• "We anticipate that our operating income and cash flows will be sufficient to operate our business and meet any commitments for the foreseeable future."
• "Management believes its liquidity and sources of capital are satisfactory for the Companys needs in the foreseeable future."

Industry Context

StockSavvy.ai notes that Chemed's performance reflects a common trend in service-based industries where revenue growth can be influenced by a combination of service volume, pricing power, and reimbursement rates, as seen in the divergence between VITAS and Roto-Rooter. The significant stock buyback activity also aligns with a broader market trend of companies returning capital to shareholders amidst economic uncertainties.

Comparison to Industry Standards

• VITAS's average daily census (ADC) of 22,723 for Q1 2026 is a key operational metric in the hospice care industry. The median length of stay of 15.0 days is relatively short, which is typical for hospice care where patients are terminally ill.
• Roto-Rooter's plumbing and drain cleaning services operate in a highly fragmented market. The company's strategy of using a mix of company-owned branches, independent contractors, and franchisees allows for broad market coverage, a common approach in the home services sector.
• The company's effective tax rate of 25.4% is within the typical range for U.S. corporations, considering federal and state tax obligations.

Legal Proceedings

• VITAS received a demand letter for $50.3 million related to an audit of elevated level-of-care hospice services; an Administrative Law Judge ruled in favor of VITAS for most claims, reducing the overpayment to a de minimis amount.
• Multiple class action lawsuits were filed against VITAS following a cybersecurity incident and data breach on October 24, 2025; these have been consolidated and settled for a non-material amount covered by insurance.

Stakeholder Impact

• Shareholders may benefit from the significant stock repurchase program, which can increase earnings per share and shareholder value.
• Employees are noted as the company's most critical resource, with a focus on service-based operations.
• Customers of VITAS receive hospice care, while Roto-Rooter customers receive plumbing and related services.
• Suppliers of pharmaceuticals and medical supplies to VITAS are critical, with a reliance on a single vendor for a large majority of purchases.
• Creditors are impacted by the company's debt covenants and its ability to service its debt, with a new credit facility providing enhanced liquidity.

Next Steps

• Continue to monitor macroeconomic trends and their potential impact on net sales and profitability.
• Evaluate potential offsetting actions for cost increases through pricing and cost savings efforts for fiscal year 2027 planning.
• Continue to evaluate cash utilization alternatives, including share repurchases, debt repurchases, acquisitions, and increased dividends.
• The company will continue to assess goodwill for impairment on a yearly basis as of October 1.

Key Dates

Recommendation

The filing shows stable revenue growth driven by the VITAS segment and a strong commitment to capital return via share buybacks. However, the slight decrease in net income and EPS, coupled with the decline in Roto-Rooter's performance and ongoing macroeconomic uncertainties, suggest a 'hold' recommendation until a clearer growth trajectory emerges or Roto-Rooter's performance stabilizes.

Keywords

Chemed Corporation, Form 10-Q, Quarterly Report, VITAS Healthcare, Roto-Rooter, Hospice Care, Plumbing Services, Financial Results, Revenue, Net Income, EPS, Stock Repurchase